Persistence and adherence with Exforge HCT single pill combination versus amlodipine/valsartan/ hydrochlorothiazide free combination: a comparison controlling for demographic and clinical factors

被引：0
|
作者：
Ong, S. [1 ]
Machnicki, G. [2 ]
Chen, W. [3 ]
Wei, Z. J. [3 ]
Kahler, K. H. [4 ]
机构：
[1] Novartis Pharma AG, Basel, Switzerland
[2] Novartis Argentina SA, Buenos Aires, DF, Argentina
[3] Novartis Pharma Co Ltd China, Shanghai, Peoples R China
[4] Novartis Pharmaceut, E Hanover, NJ USA
来源：
EUROPEAN HEART JOURNAL | 2014年 / 35卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P437
引用
收藏
页码：65 / 65
页数：1
相关论文
共 31 条
  • [1] COMPARISON OF EXFORGE HCT SINGLE PILL COMBINATION AND AMLODIPINE/VALSARTAN/HYDROCHLOROTHIAZIDE FREE COMBINATION: ADHERENCE AND PERSISTENCE
    Machnicki, G.
    Ong, S. H.
    Chen, W.
    Wei, Z.
    Kahler, K.
    [J]. VALUE IN HEALTH, 2014, 17 (03) : A119 - A120
  • [2] Comparison of Exforge HCT single pill combination and amlodipine/valsartan/ hydrochlorothiazide free combination: healthcare resource utilization and costs
    Ong, S.
    Machnicki, G.
    Chen, W.
    Wei, Z. J.
    Kahler, K. H.
    [J]. EUROPEAN HEART JOURNAL, 2014, 35 : 64 - 64
  • [3] Comparison of amlodipine/valsartan/hydrochlorothiazide single pill combination and free combination: adherence, persistence, healthcare utilization and costs
    Machnicki, G.
    Ong, S. H.
    Chen, W.
    Wei, Z. J.
    Kahler, K. H.
    [J]. CURRENT MEDICAL RESEARCH AND OPINION, 2015, 31 (12) : 2287 - 2296
  • [4] HEALTH CARE UTILIZATION AND COST COMPARISON BETWEEN ADHERENT HYPERTENSION PATIENTS TREATED BY SINGLE EXFORGE HCT AND AMLODIPINE/VALSARTAN/HYDROCHLOROTHIAZIDE FREE COMBINATION
    Chen, W.
    Wei, Z.
    Ong, S. H.
    Machnicki, G.
    Kristijan, K.
    [J]. VALUE IN HEALTH, 2014, 17 (07) : A723 - A723
  • [5] THE COST EFFECTIVENESS OF AMLODIPINE VALSARTAN AND HYDROCHLOROTHIAZIDE SINGLE PILL COMBINATION IN TURKEY
    Guclu, H.
    Berktas, M.
    Sencan, N.
    Ozbay, L.
    [J]. VALUE IN HEALTH, 2012, 15 (07) : A372 - A372
  • [6] A noninferiority comparison of valsartan/hydrochlorothiazide combination versus amlodipine in black hypertensives
    Weir, MR
    Ferdinand, KC
    Flack, JM
    Jamerson, KA
    Daley, W
    Zelenkofske, S
    [J]. HYPERTENSION, 2005, 46 (03) : 508 - 513
  • [7] Evaluation of effectiveness and safety of amlodipine/valsartan/hydrochlorothiazide single-pill combination therapy in hypertensive patients: an observational study
    Hagendorff, Andreas
    Kurz, Ira
    Mueller, Alfons
    Klebs, Sven
    [J]. JOURNAL OF DRUG ASSESSMENT, 2014, 3 (01) : 1 - 9
  • [8] Efficacy and safety of amlodipine/valsartan/hydrochlorothiazide single pill combination in Egyptian patients with hypertension uncontrolled on any dual therapy: an observational study
    El-Etriby, Adel Mohamed Kamal
    Rakha, Sameh
    [J]. CURRENT MEDICAL RESEARCH AND OPINION, 2020, 36 (04) : 537 - 544
  • [9] Compliance and persistence of free-combination antihypertensive therapy versus single-pill combination in Korean hypertensive patients
    Min, Jin-Young
    Min, Kyoung-Bok
    Hong, Ji-Min
    Kim, Eu-Gene
    Yang, Bong-Min
    [J]. INTERNATIONAL JOURNAL OF CARDIOLOGY, 2013, 168 (04) : 4576 - 4577
  • [10] Chart review of patients receiving valsartan-amlodipine single-pill combination versus valsartan and amlodipine combination for blood pressure goal achievement and effects on the Hamilton anxiety rating/Hamilton depression rating scales
    Yin, Gang
    Li, Yuefan
    Xu, Wenjie
    Han, Na
    [J]. MEDICINE, 2019, 98 (51)
1234